References
- Reeves TJ, Oberman A. Jones WB, et al. Natural history of angina pectoris. Am J Cardiol 1974: 33: 423–30
- Masseri A. Severi S, DeNes M, et al. Variant angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenic mechanisms, estimated incidence, clinical and coronary arteriographic findings in 138 patients. Am J Cardiol 1978: 42: 1019
- Prinzmetal M, Kennamer R, Merliss R. et al. Angina pectoris. I. A variant form of angina pectoris: preliminary report. Am J Med 1959: 27: 375–88
- Selzer A, Langston M, Ruggeroli C, et al. Clinical syndrome of variant angina with normal coronary arteriogram. N Engl J Med 1976: 295: 1343–7
- Williams D. Effects of antianginal agents on coronary circulation. Am Heart J 1981: 101: 473
- Flaherty J. Intravenous hemodynamic effects of nitroglycerine. Circulation 1975: 51: 132
- Nies AS, Shand DG. Clinical pharmacology of propranolol. Circulation 1975: 52: 6
- Shand DG. Drug therapy: propranolol. N Engl J Med 1975: 293: 280–5
- van Herwaarden CL, Binkhorst RA, Fennis JF, et al. Effects of adrenaline during treatment with propranolol and metoprolol. (Letter) Br Med J 1977: 1: 1029
- Norwegian Multicenter Study Group. Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981: 304: 801
- Artman E, Stone P. Muller J, et al. Calcium channel blocking agents in the treatment of cardiovascular disorders. Ann Intern Med 1980: 93: 875,886
- Ono H, Hasimoto K. Ca-antagonists in various parameters of cardiac function including coronary dilatation, with the use of nifedipine, verapamil and perhexlllne. In: Winbury MM. Abiko Y. eds. Ischemic myocardium and antianginal drugs. New York: Raven Press. 1979: 77
- Low R. Takeda P, Mason D, et al. The effects of calcium channel blocking agents on cardiovascular function. Am J Cardiol 1982: 49: 547